Legacy and newer players survive by grassroots and grit—local cannabis pioneers adapt and thrive despite hurdles.

Berkeley Patients Group: Pioneering advocacy, equity, and access in cannabis since the early days of Prop 215.

YouTube video by Fields of Green for ALL

Our colleagues Kenzi and Farid from the Cannabis Embassy, went to the Palais De Nations in Geneva on 19 February 2025, to smoke a joint on the Centenary of Cannabis Prohibition, to take a moment to re...

The legislation would block the current 15% retail tax from automatically jumping to 19% on July 1.

Hello Friends and Family- As most know, Wade has been dealing with an incurable cancer… Monica Senter needs your support for Help Wade Get Essential Home Care

Discover how Berkeley Patients Group, the nation’s longest-running dispensary, has shaped cannabis advocacy, c

Research shows that non-psychoactive compounds in the cannabis plant, such as CBD, CBG, and CBN, could provide a safer alternative to pain therapy than the drugs currently used

The researchers on this study tested a cannabis extract and found that it showed no significant genotoxic effects in any of the tested models.

Over 4,000 scientific papers specific to cannabis published in the last year

Millions of people in the U.S. report using marijuana daily or nearly every day, and those people now outnumber those who say they are daily or nearly-daily drinkers of alcohol.

A study spanning 44 years and involving over 5,000 men challenges long-held beliefs about cannabis and cognition.

A Drug Enforcement Administration (DEA) judge has denied a cannabis research company’s request to allow it to add a young medical marijuana patient and advocate as a witness in an upcoming hearing on ...

Directive issued following investigation by the Inspector General

This landmark celebrates the story of education, activism, and the pioneering spirit of Oaksterdam University.

The Berkeley Patients Group, with the mission of bringing cannabis to the sick and dying, spent many years fending off federal crackdowns.

Patients self-reported very good efficacy and tolerability of MC. There was no evidence suggesting that specific MC strains are superior depending on the disease to be treated.

Research suggests there is potential to reduce alcohol and drug use related harms of more dangerous substances through substitution with cannabis. This case study is the first to document cannabis don...

Background The survey of Copeia captured early 2022 patient-reported outcomes (PRO) in Germany under cannabis medicinal product (CAM) therapy, with particular attention to symptoms, symptom changes, i...

Among individuals with affective symptoms, naturalistic use of cannabis was associated with better sleep quality, particularly for those using edible and CBD dominant products.

Patients estimated medical cannabis could treat more than half of their spine pain, with one in three patients already using medical cannabis. 79% of patients also believe cannabis could reduce opioid...

Use of cannabis among cancer patients may be related to their treatment and is positively associated with cancer-related pain. Future research should investigate the associations of cannabis use, symp...